These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8076384)
1. New serum markers for small-cell lung cancer. I. The ganglioside fucosyl-GM1. Vangsted A; Drivsholm L; Andersen E; Pallesen T; Zeuthen J; Wallin H Cancer Detect Prev; 1994; 18(3):221-9. PubMed ID: 8076384 [TBL] [Abstract][Full Text] [Related]
2. New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM. Vangsted A; Drivsholm L; Andersen E; Bock E Cancer Detect Prev; 1994; 18(4):291-8. PubMed ID: 7982239 [TBL] [Abstract][Full Text] [Related]
3. Immunochemical detection of a small cell lung cancer-associated ganglioside (FucGM1) antigen in serum. Vangsted AJ; Clausen H; Kjeldsen TB; White T; Sweeney B; Hakomori S; Drivsholm L; Zeuthen J Cancer Res; 1991 Jun; 51(11):2879-84. PubMed ID: 1851663 [TBL] [Abstract][Full Text] [Related]
4. Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase. Drivsholm L; Vangsted A; Pallesen T; Hansen M; Dombernowsky P; Hirsch F; Hansen HH Ann Oncol; 1994 Sep; 5(7):623-6. PubMed ID: 7993838 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1. Vangsted AJ; Zeuthen J Acta Oncol; 1993; 32(7-8):845-51. PubMed ID: 8305235 [TBL] [Abstract][Full Text] [Related]
6. Serum immunoassay of a small cell lung cancer associated ganglioside: development of a sensitive scintillation proximity assay. Pallesen T; Vangsted A; Drivsholm L; Clausen H; Zeuthen J; Wallin H Glycoconj J; 1992 Dec; 9(6):331-5. PubMed ID: 1339041 [TBL] [Abstract][Full Text] [Related]
7. Small cell lung cancer is not associated with the presence of anti-fucosyl-GM1 ganglioside autoantibodies reactive in immunoenzymatic test. Adler G; Pacuszka T; Lewartowska A; Rowinska E; Oblakowski P; Panasiewicz M Lung Cancer; 2001 Dec; 34(3):383-5. PubMed ID: 11714535 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer. Dickler MN; Ragupathi G; Liu NX; Musselli C; Martino DJ; Miller VA; Kris MG; Brezicka FT; Livingston PO; Grant SC Clin Cancer Res; 1999 Oct; 5(10):2773-9. PubMed ID: 10537341 [TBL] [Abstract][Full Text] [Related]
9. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin. Krug LM; Ragupathi G; Hood C; Kris MG; Miller VA; Allen JR; Keding SJ; Danishefsky SJ; Gomez J; Tyson L; Pizzo B; Baez V; Livingston PO Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6094-100. PubMed ID: 15447995 [TBL] [Abstract][Full Text] [Related]
10. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker. Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441 [TBL] [Abstract][Full Text] [Related]
11. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Milman N; Pedersen LM Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer]. Yang J; Li R; Li A Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234 [TBL] [Abstract][Full Text] [Related]
13. CEA is an independent prognostic indicator that is associated with reduced survival and liver metastases in SCLC. Yang X; Wang D; Yang Z; Qing Y; Zhang Z; Wang G; Yang Z; Wang Z Cell Biochem Biophys; 2011 Mar; 59(2):113-9. PubMed ID: 20945115 [TBL] [Abstract][Full Text] [Related]
14. [The use of monoclonal antibodies in the detection of small cell lung cancer metastases in bone marrow]. Obłakowski P; Pacuszka T; Rogińska E; Remiszewski P; Załeska J; Zych J; Roszkowski K; Rowińska-Zakrzewska E Pneumonol Alergol Pol; 1999; 67(1-2):53-9. PubMed ID: 10481525 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
16. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies. Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088 [TBL] [Abstract][Full Text] [Related]
17. A Novel, Fully Human Anti-fucosyl-GM1 Antibody Demonstrates Potent Ponath P; Menezes D; Pan C; Chen B; Oyasu M; Strachan D; LeBlanc H; Sun H; Wang XT; Rangan VS; Deshpande S; Cristea S; Park KS; Sage J; Cardarelli PM Clin Cancer Res; 2018 Oct; 24(20):5178-5189. PubMed ID: 30021910 [No Abstract] [Full Text] [Related]
18. [Prognostic factors in patients with small cell lung cancer]. Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646 [TBL] [Abstract][Full Text] [Related]
19. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA. Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150 [TBL] [Abstract][Full Text] [Related]
20. Genetic mechanisms for the synthesis of fucosyl GM1 in small cell lung cancer cell lines. Tokuda N; Zhang Q; Yoshida S; Kusunoki S; Urano T; Furukawa K; Furukawa K Glycobiology; 2006 Oct; 16(10):916-25. PubMed ID: 16880505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]